Aptevo Therapeutics Inc (APVO) News Headlines

▮ More

Date

Headline

12/6/2019 9:16:44 AM Aptevo Therapeutics Secures Orphan Drug Designation From FDA For APVO436 For Acute Myelogenous Leukemia

12/13/2018 9:02:44 AM Aptevo Doses First Patient In Phase 1/1b Trial Of Lead Next-Generation Bispecific Antibody APVO436

11/9/2018 12:02:56 AM Alligator Bioscience And Aptevo Therapeutics Present New Preclinical Data For ALG.APV-527 At SITC Annual Meeting

10/30/2018 8:53:46 PM DXR Heartened By New Data, APVO Braces For Busy Months, AMED In Good Health

9/4/2018 10:48:11 AM Is There Still Room To Run For These Biotech Stocks?

5/15/2018 9:52:41 PM MEIP Gets Funded, PFNX Riding High, GNPX Turns Heads

5/10/2018 9:02:55 AM Aptevo Therapeutics Posts Q1 Net Loss Of $13.9 Mln Or $0.63/share

5/1/2018 9:04:43 AM Aptevo Therapeutics Announces IND Submission For APVO436

4/16/2018 8:59:50 PM APVO Walks The Talk, Eleven Bio Gains Over 13%, PADDOCK Data Boosts APLS

4/11/2018 9:11:02 PM CBAY Walks The Talk, MYND Explodes, NITE Sparkles, NVLN Awaits CHMP Opinion

3/13/2018 9:06:21 AM Aptevo Therapeutics 2017 Net Income $7.0 Mln Or $0.33/shr Vs. Loss Of $112.4 Mln Or $5.55/shr Prior Year

1/17/2018 8:47:01 PM JUNO Flies On Takeover Rumor, PRTO For Long Haul, SUPN Gaining Strength

1/8/2018 9:07:10 AM Aptevo Therapeutics Begins Patient Dosing In Phase 2 Clinical Evaluation Of Otlertuzumab In New Indication

1/2/2018 8:07:32 PM INSY On A High, KIDS Making Giant Strides, No Stopping APVO, EDIT Uncut

Older Articles